Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.30 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4652199 | 0.82 | — | — | |
| SCHEMBL7108526 | 0.81 | — | — | |
| SCHEMBL14165997 | 0.81 | — | — | |
| SCHEMBL2548651 | 0.80 | GABBR2 (0.34) | ALDH1A1GABBR2GABBR1 | |
| SCHEMBL2554809 | 0.78 | — | — | |
| SCHEMBL15513614 | 0.78 | — | — | |
| SCHEMBL56703 | 0.77 | ALDH1A1 (0.32) | ALDH1A1GABBR2GABBR1 | |
| SCHEMBL18129932 | 0.77 | DNM1 (0.37) | — | |
| SCHEMBL2827743 | 0.76 | — | — | |
| SCHEMBL1605629 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108137621-B | Novel method for preparing aminosilane compounds | 株式会社LG化学 | 2021-07-06 | — | — | CN | claimed |
| US-12570899-B2 | Bright silver based quaternary nanostructures | SHOEI CHEMICAL INC. (JP) | 2026-03-10 | — | — | US | disclosed |
| US-20240263069-A1 | BRIGHT SILVER BASED QUATERNARY NANOSTRUCTURES | SHOEI CHEMICAL INC. (JP) | 2024-08-08 | — | — | US | disclosed |
| US-11970646-B2 | Bright silver based quaternary nanostructures | SHOEI CHEMICAL INC. (JP) | 2024-04-30 | — | — | US | disclosed |
| EP-3816247-B1 | CURING MIXTURE | EVONIK OPERATIONS GMBH (DE) | 2022-12-07 | — | — | EP | disclosed |
| US-20220228057-A1 | BRIGHT SILVER BASED QUATERNARY NANOSTRUCTURES | NANOSYS, INC. (US) | 2022-07-21 | — | — | US | disclosed |
| US-11254819-B2 | Curing agent mixture | EVONIK OPERATIONS GMBH (DE) | 2022-02-22 | — | — | US | disclosed |
| EP-3924437-A1 | RESIN COMPOSITIONS AND METHODS OF PRODUCTION | Momentive Performance Materials Inc. (US) | 2021-12-22 | — | — | EP | disclosed |
| EP-2994495-B2 | CROSSLINKING OF IPMS ADDUCTS AND AMINOSILANES | EVONIK OPERATIONS GMBH (DE) | 2021-09-22 | — | — | EP | disclosed |
| CN-108137621-B | Novel method for preparing aminosilane compounds | 株式会社LG化学 | 2021-07-06 | — | — | CN | disclosed |
| US-5395886-A | Modified fluorohydrocarbon polymers | DOW CORNING CORPORATION (US) | 1995-03-07 | — | — | US | disclosed |
| EP-0396246-B1 | Ultraviolet cured silicone gels with controlled modulus and viscosity | DOW CORNING (US) | 1995-03-01 | — | — | EP | disclosed |
| US-5367023-A | Modified fluorohydrocarbon polymers | DOW CORNING CORPORATION (US) | 1994-11-22 | — | — | US | disclosed |
| EP-0507468-A2 | Modified fluorohydrocarbon polymers | DOW CORNING CORPORATION (US) | 1992-10-07 | — | — | EP | disclosed |
| EP-0230342-B1 | ACRYL FUNCTIONAL SILICONE COMPOUNDS | DOW CORNING CORPORATION (US) | 1992-08-19 | — | — | EP | disclosed |
| EP-0400786-A2 | Heat stable acrylamide polysiloxane composition | DOW CORNING CORPORATION (US) | 1990-12-05 | — | — | EP | disclosed |
| EP-0396246-A2 | Ultraviolet cured silicone gels with controlled modulus and viscosity | DOW CORNING CORPORATION (US) | 1990-11-07 | — | — | EP | disclosed |
| US-4849461-A | PHOTOCURABLE ADHESION PROMOTERS | DOW CORNING CORPORATION (US) | 1989-07-18 | — | — | US | disclosed |
| US-4697026-A | NONCATALYTIC REACTION OF AN AMINE-CONTAINING SILANOL AND A DI OR MULTI-UNSATURATED ACRY COMPOUND; PURITY | DOW CORNING CORPORATION (US) | 1987-09-29 | — | — | US | disclosed |
| EP-0230342-A2 | Acryl functional silicone compounds | DOW CORNING CORPORATION (US) | 1987-07-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570899-B2 | Bright silver based quaternary nanostructures | LGALS3, ANXA3, ATXN2L | ALDH1A1 584/4885GABBR2 3569/4885GABBR1 3970/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.